Questions arise on antiulcerant effect of COX-2 inhibitor

Published: 2002-12-31 06:58:00

Updated: 2002-12-31 06:58:00

Cyclooxygenase-2 (COX-2) inhibitor, a novel nonsteroidal anti-inflammatory drug (NSAID), has been used to treat arthritis by highlighting its advantage in advertisement over other NSAIDs in that COX-2 inhibitor causes less inflammation and ulceration of the stomach and intestine.

The salient ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK